About Biocon Biocon's Products & Services Research & Development Biocon's Technology Investors Media Careers CSR
Biocon-Media
  > MEDIA
  Overview
  Press Releases
  Media Stories
  Download Center
  Video Gallery
  Photo Gallery
  Media Contacts
  
  
     
 

Press Releases

2017 2018 2019
2016 2015 2014 2013 2012 2011
2010 2009 2008 2007 2006 2005

 
  June 2019
14 June Biocon Biologics Facilities in Bengaluru Receive EU GMP Certification Download Pdf
  May 2019
22 May Health Canada Approves Biocon and Mylan's Ogivri™, the First Trastuzumab Biosimilar, for the Treatment of HER2-Positive Breast and Gastric Cancers Download Pdf
16 May Biocon and Mylan to Present Final Overall Survival Data for Ogivri ™(trastuzumab-dkst), a biosimilar to Herceptin ®, at the American Society of Clinical Oncology (ASCO) Annual Meeting Download Pdf
07 May Company Statement: Biocon Retains Economic Interest in Global Commercialization of Hulio®, (biosimilar Adalimumab) in-licensed by Mylan Download Pdf
  April 2019
25 Apr Biocon Q4FY19 Revenue Rs 1,557 Cr, Up 26%;EBITDA Up 43% at Rs 431 Cr; Net Profit Up 64% at Rs 214 Cr FY19 Revenue Up 31% at Rs 5,659 Cr; Net Profit Up 143% at Rs 905 Cr Board Recommends 1: 1 Bonus Shares Download Pdf
  March 2019
13 Mar Kiran Mazumdar-Shaw Conferred With Honorary Doctorate from Deakin University, Australia Download Pdf
06 Mar Company Statement : Biocon Facility Completes Pre Approval U.S. FDA Inspection Download Pdf
01 Mar Biocon Appoints Dr. Christiane Hamacher as CEO Of Biocon Biologics India Limited Download Pdf
  February 2019
18 Feb Company Statement : Biocon Facilities complete Pre Approval U.S.FDA lnspection Download Pdf
  January 2019
24 Jan Biocon Q3FY19 Earnings Revenue at Rs 1,566 Cr, Up 43%; Net Profit at Rs 217 Cr, Up 136% EBITDA at Rs 406 Cr, Up 59% Download Pdf
   
 
 
 
 
     
  Biocon

Businesses

Recommended sites Biocon on  
  Home
About Us

Investor Relations
Media Relations
Careers
Site Map
Contact Us
Our Growth Accelerators
Fact Sheet
Branded Formulations
Biopharmaceuticals
Research Services
Active Discovery Program

ABLE
Karnataka Vision Group on BT
Syngene International
Biocon Academy

    Linked In   
       
  Report adverse event/side effects and product complaints    
       
  * Disclaimer            © 2018, Biocon. All Rights Reserved